Oro Valley Hospital LLC
Oro Valley Hospital LLC was paid $12.98M by Medicaid between Jan 2018 and Dec 2024, across 160 billing codes. Its largest line is 99283, emergency room visit (moderate) — 20% of everything it billed.
ORO VALLEY, AZ 85755
Next to other Urgent Care Clinic/Center providers in Arizona
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Auditor's notes
Automated statistical signals. Not evidence of fraud — how these are computed.
Paid by month
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 52,249 | $1.75M | |
| 2019 | 51,870 | $2.06M | |
| 2020 | 41,132 | $1.62M | |
| 2021 | 46,759 | $1.57M | |
| 2022 | 60,806 | $2.15M | |
| 2023 | 60,571 | $2.09M | |
| 2024incomplete | 47,946 | $1.73M |
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 20% | 17,355 | 16,325 | $2.61M |
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 16% | 15,321 | 13,908 | $2.08M |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | 14% | 3,786 | 3,537 | $1.80M |
| 99285 | Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life | 13% | 7,737 | 6,872 | $1.65M |
| 70450 | Computed tomography, head or brain; without contrast material | 7.5% | 3,791 | 3,502 | $969K |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | 6.6% | 2,095 | 1,974 | $857K |
| G0378 | Hospital observation service, per hour | 3.6% | 2,433 | 1,782 | $463K |
| 71275 | Computed tomographic angiography, chest, with contrast material | 2.8% | 952 | 885 | $363K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 2.4% | 3,751 | 3,608 | $316K |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | 2.1% | 3,092 | 2,630 | $269K |
| C1776 | Joint device (implantable) | 1.5% | 169 | 155 | $200K |
| C1713 | Anchor/screw for opposing bone-to-bone or soft tissue-to-bone (implantable) | 1.5% | 1,189 | 1,094 | $192K |
148 more codes
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | <1% | 624 | $107K |
| 43239 | Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple | <1% | 293 | $99K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 2,210 | $95K |
| 99213 | Doctor's office visit, returning patient (routine) | <1% | 1,425 | $81K |
| 95810 | Polysomnography; sleep staging with 4 or more additional parameters | <1% | 115 | $73K |
| 95811 | <1% | 133 | $70K | |
| 71046 | Radiologic examination, chest; 2 views | <1% | 3,609 | $53K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 5,172 | $43K |
| 97112 | Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination | <1% | 870 | $42K |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | <1% | 1,860 | $38K |
| 45380 | Colonoscopy, flexible; with biopsy, single or multiple | <1% | 132 | $33K |
| 45378 | Colonoscopy, flexible; diagnostic, including collection of specimen(s) | <1% | 82 | $28K |
| 96361 | Intravenous infusion, hydration; each additional hour | <1% | 8,424 | $28K |
| 97530 | Therapeutic activities, direct patient contact, each 15 minutes | <1% | 1,337 | $27K |
| 97140 | Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) | <1% | 943 | $26K |
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | <1% | 599 | $25K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | <1% | 11,147 | $23K |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 1,878 | $19K |
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | <1% | 402 | $19K |
| 80053 | Comprehensive metabolic panel | <1% | 16,442 | $18K |
| 73564 | <1% | 369 | $17K | |
| 76705 | Ultrasound, abdominal, real time with image documentation; limited | <1% | 573 | $16K |
| 72125 | Computed tomography, cervical spine; without contrast material | <1% | 420 | $15K |
| 99214 | Doctor's office visit, returning patient (more involved) | <1% | 257 | $14K |
| 99203 | Doctor's office visit, new patient (routine) | <1% | 207 | $13K |
| 45385 | Colonoscopy, flexible; with removal of tumor(s), polyp(s), or other lesion(s) | <1% | 82 | $13K |
| 70551 | Magnetic resonance imaging, brain; without contrast material | <1% | 26 | $13K |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | <1% | 680 | $11K |
| 64447 | <1% | 357 | $11K | |
| 76856 | Ultrasound, pelvic (nonobstetric), real time with image documentation; complete | <1% | 150 | $10K |
| 93971 | <1% | 115 | $10K | |
| 84484 | <1% | 8,198 | $9K | |
| 73610 | <1% | 518 | $8K | |
| 96366 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour | <1% | 103 | $8K |
| 73630 | <1% | 760 | $7K | |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | <1% | 2,823 | $7K |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | <1% | 10,512 | $7K |
| 73130 | <1% | 356 | $7K | |
| 96375 | Therapeutic injection; each additional sequential IV push | <1% | 6,813 | $6K |
| 71045 | Radiologic examination, chest; single view | <1% | 6,795 | $6K |
| 77067 | Screening mammography, bilateral, including computer-aided detection | <1% | 52 | $5K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 22,926 | $4K |
| 88342 | <1% | 253 | $4K | |
| 95806 | <1% | 45 | $4K | |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | <1% | 1,362 | $4K |
| 72100 | <1% | 212 | $3K | |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 7,731 | $3K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 3,501 | $2K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 3,277 | $2K |
| 93976 | <1% | 320 | $2K | |
| 87636 | Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B | <1% | 1,140 | $2K |
| 73030 | <1% | 321 | $2K | |
| 64450 | <1% | 75 | $1K | |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 2,254 | $1K |
| 12001 | <1% | 12 | $1K | |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 3,896 | $1K |
| C9803 | Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | <1% | 5,048 | $1K |
| 96376 | <1% | 1,367 | $1K | |
| 73110 | <1% | 96 | $1K | |
| G0463 | Hospital outpatient clinic visit for assessment and management of a patient | <1% | 99 | $1K |
| 36415 | Collection of venous blood by venipuncture | <1% | 26,166 | $1K |
| 70498 | <1% | 14 | $963.03 | |
| 71250 | <1% | 13 | $961.71 | |
| 82248 | <1% | 1,077 | $795.08 | |
| 87186 | <1% | 1,312 | $776.46 | |
| 81001 | <1% | 6,830 | $760.57 | |
| 84703 | <1% | 5,015 | $695.56 | |
| 83690 | <1% | 7,487 | $686.65 | |
| 97161 | <1% | 94 | $588.31 | |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 1,674 | $447.78 |
| 85610 | <1% | 3,299 | $440.21 | |
| 87070 | <1% | 16 | $311.49 | |
| 87040 | <1% | 1,154 | $306.05 | |
| 85379 | <1% | 1,876 | $275.27 | |
| 81025 | <1% | 3,347 | $264.97 | |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 9,031 | $229.95 |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 7,641 | $179.72 |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 3,915 | $175.82 |
| J0690 | Injection, cefazolin sodium, 500 mg | <1% | 2,928 | $170.55 |
| 80061 | Lipid panel | <1% | 91 | $152.16 |
| 81003 | <1% | 6,242 | $148.77 | |
| 83605 | <1% | 1,282 | $147.21 | |
| 82077 | <1% | 1,485 | $129.14 | |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | <1% | 5,500 | $118.60 |
| J1170 | Injection, hydromorphone, up to 4 mg | <1% | 2,985 | $111.10 |
| J2274 | Injection, morphine sulfate, preservative-free for epidural or intrathecal use, 10 mg | <1% | 882 | $108.21 |
| 87077 | <1% | 1,321 | $107.09 | |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 313 | $100.89 |
| 83735 | <1% | 2,898 | $90.62 | |
| 85027 | <1% | 983 | $89.87 | |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | <1% | 162 | $89.71 |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | <1% | 156 | $89.48 |
| 83880 | <1% | 698 | $76.04 | |
| J2060 | Injection, lorazepam, 2 mg | <1% | 1,721 | $70.22 |
| J0171 | Injection, adrenalin, epinephrine, 0.1 mg | <1% | 572 | $69.02 |
| J2270 | Injection, morphine sulfate, up to 10 mg | <1% | 3,026 | $68.37 |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | <1% | 1,462 | $65.18 |
| 94760 | <1% | 3,260 | $63.33 | |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 468 | $62.80 |
| U0002 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc | <1% | 570 | $59.71 |
| J3010 | Injection, fentanyl citrate, 0.1 mg | <1% | 3,823 | $56.10 |
| 82947 | <1% | 3,528 | $47.34 | |
| 85730 | <1% | 920 | $42.18 | |
| 90715 | <1% | 332 | $38.10 | |
| J7030 | Infusion, normal saline solution , 1000 cc | <1% | 2,912 | $38.05 |
| 84702 | <1% | 58 | $33.62 | |
| 80143 | <1% | 892 | $30.84 | |
| 80179 | <1% | 866 | $30.84 | |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 1,771 | $29.36 |
| J2795 | Injection, ropivacaine hydrochloride, 1 mg | <1% | 1,496 | $24.00 |
| 84100 | <1% | 182 | $7.63 | |
| 82550 | <1% | 194 | $4.69 | |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | <1% | 3,093 | $3.81 |
| J0665 | Injection, bupivicaine, not otherwise specified, 0.5 mg | <1% | 263 | $3.00 |
| J2704 | Injection, propofol, 10 mg | <1% | 5,349 | $2.60 |
| 86901 | <1% | 147 | $2.46 | |
| 86900 | <1% | 147 | $2.38 | |
| J1790 | Injection, droperidol, up to 5 mg | <1% | 159 | $2.14 |
| 87400 | 0% | 176 | $0.00 | |
| J2710 | Injection, neostigmine methylsulfate, up to 0.5 mg | 0% | 205 | $0.00 |
| J3370 | Injection, vancomycin hcl, 500 mg | 0% | 545 | $0.00 |
| J2930 | Injection, methylprednisolone sodium succinate, up to 125 mg | 0% | 57 | $0.00 |
| 84439 | 0% | 37 | $0.00 | |
| A9576 | Injection, gadoteridol, (prohance multipack), per ml | 0% | 27 | $0.00 |
| C9113 | Injection, pantoprazole sodium, per vial | 0% | 55 | $0.00 |
| J3475 | Injection, magnesium sulfate, per 500 mg | 0% | 26 | $0.00 |
| G8978 | Mobility: walking & moving around functional limitation, current status, at therapy episode outset and at reporting intervals | 0% | 34 | $0.00 |
| J1596 | Injection, glycopyrrolate, 0.1 mg | 0% | 19 | $0.00 |
| J1650 | Injection, enoxaparin sodium, 10 mg | 0% | 54 | $0.00 |
| J7040 | Infusion, normal saline solution, sterile (500 ml = 1 unit) | 0% | 27 | $0.00 |
| G8979 | Mobility: walking & moving around functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting | 0% | 34 | $0.00 |
| J1171 | Injection, hydromorphone, 0.1 mg | 0% | 40 | $0.00 |
| 77063 | Screening digital breast tomosynthesis, bilateral | 0% | 52 | $0.00 |
| J7512 | Prednisone, immediate release or delayed release, oral, 1 mg | 0% | 233 | $0.00 |
| 82150 | 0% | 251 | $0.00 | |
| 87147 | 0% | 31 | $0.00 | |
| J0330 | Injection, succinylcholine chloride, up to 20 mg | 0% | 103 | $0.00 |
| J2765 | Injection, metoclopramide hcl, up to 10 mg | 0% | 526 | $0.00 |
| 86140 | 0% | 31 | $0.00 | |
| J3480 | Injection, potassium chloride, per 2 meq | 0% | 31 | $0.00 |
| 86850 | 0% | 12 | $0.00 | |
| 85652 | 0% | 25 | $0.00 | |
| J2543 | Injection, piperacillin sodium/tazobactam sodium, 1 gram/0.125 grams (1.125 grams) | 0% | 18 | $0.00 |
| 87205 | 0% | 30 | $0.00 | |
| J8540 | Dexamethasone, oral, 0.25 mg | 0% | 14 | $0.00 |
| 87807 | 0% | 31 | $0.00 | |
| 70496 | 0% | 14 | $0.00 | |
| 88304 | 0% | 28 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
Who's on the registration
| Provider | Location | Paid |
|---|---|---|
| Roswell Hospital Corporation | Roswell, NM | $41.27M |
| Wesley Health System LLC | Hattiesburg, MS | $37.82M |
| Metro Knoxville Hma LLC | Powell, TN | $28.70M |
| Bullhead City Hospital Corporation | Bullhead City, AZ | $28.54M |
| Iom Health System LP | Fort Wayne, IN | $27.50M |
| ST. Joseph Health System, LLC | Fort Wayne, IN | $25.43M |
| Laredo Texas Hospital Company LP | Laredo, TX | $19.46M |
| Oak Hill Hospital Corporation | Oak Hill, WV | $18.77M |
| Cocke County Hma, LLC | Newport, TN | $18.34M |
| Cleveland Tennessee Hospital Company LLC | Cleveland, TN | $16.31M |
| Jefferson County Hma LLC | Jefferson City, TN | $14.31M |
| Northwest Arkansas Hospitals, LLC | Springdale, AR | $11.46M |
| Petersburg Hospital Company LLC | Petersburg, VA | $11.20M |
| Campbell County Hma, LLC | Lafollette, TN | $10.07M |
| Warsaw Health System LLC | Warsaw, IN | $9.95M |
| Longview Medical Center LP | Longview, TX | $9.29M |
| Moberly Hospital Company LLC | Moberly, MO | $8.61M |
| Crestview Hospital Company, LLC | Crestview, FL | $8.15M |
| Kirksville Missouri Hospital Company, LLC | Kirksville, MO | $7.98M |
| Victoria of Texas LP | Victoria, TX | $7.74M |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.